Latest News On Cost Transparency

Latest KFF Health News Stories

Trump’s DOJ Accuses Medicare Advantage Insurers of Paying ‘Kickbacks’ for Primo Customers

KFF Health News Original

The Department of Justice alleges that several major health insurers paid brokerages “hundreds of millions of dollars in kickbacks” to get agents to steer consumers into their Medicare Advantage plans, allegations the insurers strongly dispute.

Proposed Rule Would Make Hospital Prices Even More Transparent

KFF Health News Original

A Biden administration proposal would help standardize the data on prices that hospitals provide to patients, increase its usefulness to consumers, and boost enforcement. Previous rules gave hospitals too many loopholes.

Decisión de Eli Lilly de bajar el precio de su insulina logrará cambios históricos en los costos

KFF Health News Original

Expertos en precios de medicamentos celebraron la noticia de Eli Lilly y otros esfuerzos. Y estas otras iniciativas para llevar al mercado insulina de menor costo, a su vez, presionarían a Eli Lilly para que mantuviera sus precios bajos.

Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.

KFF Health News Original

Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.

Nueva herramienta ayudaría a comparar costos de hasta 500 servicios médicos

KFF Health News Original

Desde el 1 de enero, las aseguradoras y los empleadores que ofrecen planes de salud deben proporcionar calculadoras en línea para que los pacientes obtengan estimaciones detalladas de lo que deberán por una variedad de servicios y medicamentos, teniendo en cuenta sus deducibles y copagos.

A Billing Expert Saved Big After Finding an Incorrect Charge in Her Husband’s ER Bill

KFF Health News Original

A medical billing specialist investigated her husband’s ER bill. Her sleuthing took over a year but knocked thousands of dollars off the hospital’s charges — and provides a playbook for other consumers.

The $18,000 Breast Biopsy: When Having Insurance Costs You a Bundle

KFF Health News Original

An online calculator told a young woman that a procedure to rule out cancer would cost an uninsured person about $1,400. Instead, the hospital initially charged almost $18,000 and, with her high-deductible health insurance, she owed more than $5,000.

Cómo evitar, o deshacerse, de una deuda médica

KFF Health News Original

Más de 100 millones de personas en el país, con o sin seguro de salud, tienen deudas médicas. Saber navegar un complejo sistema de facturación y “trampas” puede ayudar a saldarlas sin caer en bancarrota, o evitarlas.

How to Get Rid of Medical Debt — Or Avoid It in the First Place

KFF Health News Original

Medical bills can add stress to the already stressful experience of dealing with a medical crisis. And if you can’t pay those bills, they can linger, wreaking havoc on your financial goals and credit. Here’s how to protect yourself.

KHN’s ‘What the Health?’: Taking a Shot at Gun Control

KFF Health News Original

The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.

Pharmacies Face Extra Audit Burdens That Threaten Their Existence

KFF Health News Original

Pharmacy benefit managers have curtailed in-person audits of pharmacy claims during the pandemic, switching to virtual audits done by computer. That has markedly increased the number of claims they can review — and the chances for payment denials — squeezing pharmacies and bringing in more cash for the benefit companies.